ebi-005
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
3
Phase 4
0
Earliest trial started Nov 1, 2012 (NCT01748578)
Timeline
Indications
Mechanism of action
- Interleukin-1 receptorINHIBITOR
IL1R1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ebi-005
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02492321 | Phase 3 | Jul 1, 2015 | Sesen Bio |
| NCT02405039 | Phase 3 | Apr 1, 2015 | Sesen Bio |
| NCT02082899 | Phase 2 | Feb 1, 2014 | Sesen Bio |
| NCT01998802 | Phase 3 | Jan 1, 2014 | Sesen Bio |
| NCT01745887 | Phase 1 | Nov 1, 2012 | Sesen Bio |
| NCT01748578 | Phase 1 | Nov 1, 2012 | Sesen Bio |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sesen Bio | For profit | 6 | 6 | 3 | 2012 |
1 organizations
Page 1 / 1